Editor’s note: This is a developing news story. Please check back soon for updates.
Bausch + Lomb will return its enVista IOLs to market after identifying the event that led to a voluntary recall, according to a press release.
The company recalled the lenses in March after receiving reports of toxic anterior segment syndrome (TASS) among patients implanted with the IOLs in the U.S.
Bausch + Lomb conducted an investigation with the help of nearly 30 cataract surgeons, including leaders from the American Society of Cataract and Refractive Surgery, and found that raw material used in certain